Abstract:Hypoxia-ischemia is the most common cause of neonatal encephalopathy (NE). In most cases, an intrapartum event is presumed to lead to perinatal hypoxia ischemia, but the exact pathogenesis, and therefore timing, are often not known. 1 In well-resourced settings, therapeutic hypothermia (TH) reduces death and major neurodevelopmental disability in infants with NE. 2 However, there is heterogeneity in outcomes, and major neurodevelopmental disability is still seen in about one third of survivors who are treated with therapeutic hypothermia. 3 The heterogeneity in response of NE to TH means alternative treatments are desperately sought. As such, many biomarkers have been studied as surrogate measures of long-term outcome, in order to expedite assessment of potential treatments. Moreover, an important goal is to personalize treatment for NE such that individuals who might benefit from a different approach to TH, might be detected early. It is also important to study biomarkers that can discriminate between which babies benefit from TH versus those who may be at higher risk of an adverse outcome. 4 In the study by O'Gorman Tuura et al., the authors have explored the link between perfusion and neurodevelopmental outcomes using arterial spine labeling (ASL) as a neuroimaging marker for outcome prediction. 5 ASL is a noninvasive magnetic resonance imaging (MRI) technique in which protons in blood and water are magnetically labeled and the signal generated by the endogenous labels are detected by subtracting MRI signals during alternating labeled and unlabeled acquisitions. The images demonstrate signal intensity proportional to the amount of perfusion in each voxel and a quantitative measurement of cerebral blood flow (CBF) can be calculated. 6 Previous authors have described patterns of CBF using ASL in NE. Wintermark et al. demonstrated initial hypoperfusion on day 1 followed by hyperperfusion at days 2–3. 7 A study by Tang et al. reported lower CBF values in neonates with NE at 0–24 h and 3–7 days with higher values in the 1–3 day-old group. 8 The mean age at MRI in O'Gorman Tuura's paper was 5 days (range 3–9 days), which means that any hyperperfusion identified may not represent the 'peak' perfusion phase, but rather the tail end of the more severe cases. The problem with that theory is that the cohort studied included infants with mild to moderate NE and the authors found a relationship between altered perfusion and outcome even in those children with mild to moderate impairment following NE.

Cerebral Hemodynamic and Metabolic Abnormalities in Neonatal Hypocalcemia: Findings from Advanced MRI

Microstructural Alterations in Projection and Association Fibers in Neonatal Hypoxia-Ischemia.

Brain Injury in Neonatal Hypoglycemia: A Hospital-Based Cohort Study

The relationship between the MRI findings and clinical features in 22 full-term infants with neonatal hypoglycemia

Analysis of MRI Findings and Risk Factors of Neonatal Brain Injury

Middle cerebral artery velocity is associated with the severity of MRI brain injury in neonates received therapeutic hypothermia

Dynamic magnetic resonance imaging findings in the early stages of neonatal hypoglycemic brain injury

Semi-quantitative Assessment of Brain Maturation by Conventional Magnetic Resonance Imaging in Neonates with Clinically Mild Hypoxic-ischemic Encephalopathy

Cerebral blood flow in neonatal encephalopathy: biomarker or potential target?

Cerebral Glucose Concentration in Neonatal Hypoxic–Ischemic Encephalopathy during Therapeutic Hypothermia

Neonatal Brain MRI: Periventricular Germinal Matrix Mimicking Hypoxic-ischemic White Matter Injuries

Role of Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in the diagnosis of Neonatal Hypoxic-Ischemic Injury

[Diagnosis and Prognosis of Neonatal Cerebral Infarction].

Proton Magnetic Resonance Spectroscopy Biomarkers in Neonates with Hypoxic-Ischemic Encephalopathy: A Systematic Review and Meta-Analysis.

Assessment of brain structure and volume reveals neurodevelopmental abnormalities in preterm infants with low-grade intraventricular hemorrhage

The Study of the Brain Metabolism in Patients with Cyanotic Congenital Heart Disease by 1H-Magnetic Resonance Spectroscopy

Use of 2-Channel Bedside Electroencephalogram Monitoring in Term-Born Encephalopathic Infants Related to Cerebral Injury Defined by Magnetic Resonance Imaging

Relations among the Myelin Basic Protein of Serum and Coronal-Ct Manifestions, Behavioral Neurological Assessment in Neonatal Hypoxic Ischemic Encephalopathy.

Brain MR spectroscopy findings in neonates with hypothyroidism born to mothers living in iodine-deficient areas

MRI Features of Neonatal Hypoxic-ischemic Encephalopathy

Brain magnetic resonance imaging review suggests unrecognised hypoglycaemia in childhood